This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive, LAG 3 biology and Clinical Results webinar that took place on June 13, 2022.
Targets for Cancer IO: A Deep Dive Series is supported, in part, by educational grants from Genmab, US, Inc. and Merck & Co., Inc. (as of 6/6/2022).#TargetsforCancerImmunotherapyADeepDiveSeminarSeries #NoCEOffered #Industry #Researcher #2022 #MouseModels #Tcells #TumorMicroenvironment #CombinationTherapy #ImmuneCheckpointInhibitors #Nivolumab
Meeting: 2022 Targets for Cancer IO: A Deep Dive, LAG-3 Biology and Current Clinical Results; Presenters: Tullia C. Bruno, PhD – University of Pittsburgh; Presenter: Evan J. Lipson, MD – Johns Hopkins University; Drew M. Pardoll, MD, PhD – Johns Hopkins University; Dario A.A. Vignali, PhD – University of Pittsburgh; Date: June 13, 202200:21:01
Meeting: 2022 Targets for Cancer IO: A Deep Dive, LAG-3 Biology and Current Clinical Results; Presenter: Evan J. Lipson, MD – Johns Hopkins University; Date: June 13, 202200:21:16
Meeting: 2022 Targets for Cancer IO: A Deep Dive, LAG-3 Biology and Current Clinical Results; Presenter: Tullia C. Bruno, PhD – University of Pittsburgh; Date: June 13, 202200:30:15
Meeting: 2022 Targets for Cancer IO: A Deep Dive, LAG-3 Biology and Current Clinical Results; Presenter: Dario A.A. Vignali, PhD – University of Pittsburgh; Date: June 13, 202200:30:23
Meeting: 2022 Targets for Cancer IO: A Deep Dive, LAG-3 Biology and Current Clinical Results; Presenter: Drew M. Pardoll, MD, PhD – Johns Hopkins University; Date: June 13, 202200:07:46
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us